GlassScriptPhysician profile
Kenneth R Bernal
NPI 1023087434
$12,518.07
in general payments reported to CMS, 2019-2025
56 companies · $2,003 in 2025
The $2,003 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,834 · 2020: $800 · 2021: $3,211 · 2022: $1,402 · 2023: $1,256 · 2024: $2,012 · 2025: $2,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,259 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,258.76 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,429.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $1,311.86 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,067.65 | 2021-2025 | Vraylar |
| Glaxosmithkline, LLC. | $787.04 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $767.65 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $733.60 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $728.94 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $638.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $599.96 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Amgen INC. | $499.20 | 2019-2025 | Repatha, Evenity, Repatha |
| Janssen Pharmaceuticals, INC | $389.12 | 2019-2024 | Spravato |
| Astellas Pharma US INC | $263.08 | 2019-2024 | Veozah, Myrbetriq |
| Corcept Therapeutics | $202.28 | 2025 | Korlym |
| Paratek Pharmaceuticals, INC. | $184.52 | 2022-2025 | Nuzyra |
| Amarin Pharma, INC. | $175.92 | 2019-2021 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $163.41 | 2025 | Auvelity |
| Antares Pharma, INC. | $160.94 | 2023-2025 | Xyosted, Tlando |
| Sanofi-Aventis U.S. LLC | $159.70 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $151.66 | 2022-2024 | |
| Allergan, INC. | $144.06 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $139.84 | 2020-2022 | |
| Eisai INC. | $126.97 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $116.30 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $116.28 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $108.27 | 2023-2025 | Rexulti |
| Dexcom, INC. | $107.08 | 2021-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $95.61 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.14 | 2019-2024 | Trintellix |
| Madrigal Pharmaceuticals | $89.60 | 2024-2025 | Rezdiffra, Resmetirom |
| Abbott Laboratories | $82.91 | 2023-2024 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $73.33 | 2019-2025 | Zoryve |
| Lundbeck LLC | $60.62 | 2023-2025 | Rexulti, Vyepti |
| Renalytix Ai, INC. | $60.55 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Scilex Pharmaceuticals INC. | $58.96 | 2024-2025 | |
| Dynavax Technologies Corporation | $53.00 | 2024-2025 | Heplisav-B |
| Nalpropion Pharmaceuticals LLC | $51.20 | 2019 | |
| Genentech USA, INC. | $50.46 | 2019-2021 | |
| Nevro Corp. | $47.92 | 2024 | Senza |
| Sumitomo Pharma America, INC. | $45.70 | 2023-2024 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.13 | 2022-2024 | Xifaxan |
| Inspire Medical Systems, INC. | $32.79 | 2024 | Inspire |
| Ani Pharmaceuticals, INC. | $31.48 | 2025 | Purified Cortrophin Gel |
| Arbor Pharmaceuticals, INC. | $25.66 | 2021-2022 | |
| Mycovia Pharmaceuticals, INC. | $24.77 | 2022 | |
| Corium, LLC | $24.61 | 2023 | Adlarity |
| Shield Therapeutics INC | $22.97 | 2023 | Accrufer |
| Mylan Specialty L.P. | $22.16 | 2024 | Yupelri |
| Optinose US, INC. | $21.96 | 2024 | |
| Alnylam Pharmaceuticals INC. | $19.28 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.11 | 2019 | |
| Stryker Corporation | $18.38 | 2024 | Triathlon, Mako |
| Scynexis, INC. | $17.60 | 2022 | |
| Cvrx, INC. | $16.82 | 2024 | Barostim Neo System |
| Idorsia Pharmaceuticals US INC | $16.08 | 2024 | Quviviq |
| Sanofi Pasteur INC. | $16.00 | 2019 | |
| Ascend Therapeutics US, LLC | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Bernal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.